Literature DB >> 16117718

Opportunities for disease state management in prostate cancer.

A Simon Pickard1, Shih-Ying Hung, June M McKoy, Whitney P Witt, Adnan Arseven, Roohollah Sharifi, Zhigang Wu, Sara J Knight, Norene McWilliams, Glen T Schumock, Charles L Bennett.   

Abstract

In this paper, we examine how the management of prostate cancer lends itself to a disease state management (DSM)-based approach, and propose a framework that emphasizes the patient-provider-caregiver triad in managing the long-term implications of the condition. There is often no clearly superior approach to the management of patients with prostate cancer (eg, watchful waiting and hormonal therapy), and each option entails different trade-offs in quality of life. Ideally, the physician and patient discuss the options, issues, and patient preferences for treatment through the shared decision-making process. A family caregiver such as the spouse of the patient is often involved in the treatment decision and in the long-term management of the cancer experience. In order to develop a DSM program supporting both patient and caregiver, educational, psychosocial, and health care system support needs should be tailored to each phase of cancer treatment/management. To embrace the unique aspects of prostate cancer management, the proposed framework emphasizes communication among the patient-caregiver-provider triad, inclusion of family caregivers in the program, cancer phase-specific support, and psychosocial services as a basis for implementation and evaluation of a DSM program in prostate cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16117718     DOI: 10.1089/dis.2005.8.235

Source DB:  PubMed          Journal:  Dis Manag        ISSN: 1093-507X


  4 in total

1.  Employing a mobile health decision aid to improve decision-making for patients with advanced prostate cancer and their decision partners/proxies: the CHAMPION randomized controlled trial study design.

Authors:  Lourdes R Carhuapoma; Winter M Thayer; Catherine E Elmore; Jane Gildersleeve; Tanmay Singh; Farah Shaukat; Melissa K Uveges; Tamryn Gray; Crystal Chu; Daniel Song; Patricia J Hollen; Jennifer Wenzel; Randy A Jones
Journal:  Trials       Date:  2021-09-16       Impact factor: 2.728

2.  Proxy assessment of health-related quality of life in african american and white respondents with prostate cancer: perspective matters.

Authors:  A Simon Pickard; Hsiang-Wen Lin; Sara J Knight; Sara L Knight; Roohollah Sharifi; Zhigang Wu; Shih-Ying Hung; Whitney P Witt; Chih-Hung Chang; Charles L Bennett
Journal:  Med Care       Date:  2009-02       Impact factor: 2.983

3.  Responses and relationship dynamics of men and their spouses during active surveillance for prostate cancer: health literacy as an inquiry framework.

Authors:  Lars Kayser; Nete S Hansen-Nord; Richard H Osborne; Anne Tjønneland; Rikke D Hansen
Journal:  BMC Public Health       Date:  2015-08-01       Impact factor: 3.295

4.  Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.

Authors:  Ingrid J Hall; Judith Lee Smith
Journal:  Am J Prev Med       Date:  2015-12       Impact factor: 5.043

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.